Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase | |
刊名 | 医学前沿
![]() |
2015 | |
卷号 | No.3 |
关键词 | chronic myeloid leukemia imatinib dasatinib nilotinib allogeneic hematopoietic stem cell transplantation |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1999803 |
专题 | 四川大学 |
推荐引用方式 GB/T 7714 | . Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase[J]. 医学前沿,2015,No.3. |
APA | (2015).Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.医学前沿,No.3. |
MLA | "Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase".医学前沿 No.3(2015). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论